Results
|
|
1.
|
|
|
|
2.
|
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study. MedStar authors:
Year: 2020
Citation: - Lancet Oncology. 21(4):519-530, 2020 Apr.
Department: - Associate Dean for Research Development
Medline publication type:
All authors: - Benyunes MC, Ciruelos E, Clark E, CLEOPATRA study group, Cortes J, Im SA, Im YH, Kim SB, Knott A, Loi S, Miles D, Monturus E, Restuccia E, Schneeweiss A, Semiglazov V, Swain SM
|
|
|
3.
|
Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study. MedStar authors:
Year: 2022
Citation: - Journal of Clinical Oncology. 40(5):438-448, 2022 02 10.
Department: - Associate Dean for Research Development
Medline publication type:
All authors: - Barrios C, Bonnefoi H, Boulet T, De Laurentiis M, Ellis PA, Fehrenbacher L, Gianni L, Gralow J, Harbeck N, Huang CS, Im SA, Im YH, Ito Y, Krop IE, Liu H, Macharia H, Nowecki Z, Shah J, Song C, Swain SM, Toi M, Trask P, Winer EP
|
|
|
4.
|
NSABP B-41, a Randomized Neoadjuvant Trial: Genes and Signatures Associated with Pathologic Complete Response. MedStar authors:
Year: 2020
Citation: - Clinical Cancer Research. 26(16):4233-4241, 2020 08 15.
Department: - Associate Dean for Research Development
Medline publication type:
All authors: - Bandos H, Brauer HA, Geyer CE Jr, Goerlitz DS, Harris BT, Lucas PC, Mamounas EP, Rastogi P, Ren Y, Robidoux A, Swain SM, Tang G, Wolmark N
|
|
|
5.
|
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Cunningham, A
- Gallagher, Christopher
- Hofmeyer, Mark
- Srichai, M B
- Swain, Sandra M
Year: 2019
Citation: - Breast Cancer Research & Treatment. 175(3):595-603, 2019 Jun.
Institution:
- MedStar Health
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
- Washington Cancer Institute
Department: - Associate Dean for Research Development
Medline publication type:
All authors: - Asch FM, Barac A, Cunningham A, Dang C, Gallagher C, Geng X, Herbolsheimer P, Hofmeyer M, Isaacs C, Lynce F, Nunes R, Pohlmann PR, Shajahan-Haq A, Smith KL, Srichai MB, Swain SM, Tan MT, Timothee P, Warren R, Yu AF
|
|
|
6.
|
UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. [Review] MedStar authors:
Year: 2021
Citation: - Cancers. 13(7), 2021 Mar 29.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Bottiglieri S, Carballido E, Cueto AD, Hicks JK, Imanirad I, Levine R, Nelson RS, Parker AS, Seligson ND, Swain SM, Tillman EM
|
|
|
7.
|
Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer. MedStar authors:
- Lynce, Filipa
- Swain, Sandra M
Year: 2020
Citation: - Frontiers in Oncology. 10:1475, 2020.
Institution: - Washington Cancer Institute
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Elliott A, Gatalica Z, Heeke AL, Isaacs C, Khoury K, Korn WM, Lynce F, Pohlmann PR, Schwartzberg LS, Simon M, Swain SM, Tan AR, Xiu J
|
|
|
8.
|
|
|
|
9.
|
Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41. MedStar authors:
Year: 2023
Citation: - Breast Cancer Research & Treatment. 199(2):243-252, 2023 Jun.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
- Journal Article
- Randomized Controlled Trial
All authors: - Azar CA, Baez-Diaz L, Bandos H, Bear HD, Boileau JF, Brufsky AM, Geyer CE Jr Hassan S, Magrinat GC, Mamounas EP, Paik S, Rastogi P, Sarwar S, Shibata HR, Suga JM, Swain SM, Tang G, Wolmark N, Yothers G
|
|
|
10.
|
|
|
|
11.
|
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]). MedStar authors:
Year: 2024
Citation: - Journal of Clinical Oncology. 42(12):1344-1349, 2024 Apr 20.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Geyer CE Jr, Blum JL, Yothers G, Asmar L, Flynn PJ, Robert NJ, Hopkins JO, O'Shaughnessy JA, Rastogi P, Puhalla SL, Hilton CJ, Dang CT, Gomez HL, Vukelja SJ, Lyss AP, Paul D, Brufsky AM, Colangelo LH, Swain SM, Mamounas EP, Wolmark N
|
|
|
12.
|
|
|
|
13.
|
Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway. MedStar authors:
- Lynce, Filipa
- Swain, Sandra M
Year: 2020
Citation: - Breast Cancer Research & Treatment. 184(2):265-275, 2020 Nov.
Institution: - Washington Cancer Institute
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Elliott A, Heeke AL, Isaacs C, Korn WM, Lynce F, Pohlmann PR, Schwartzberg LS, Swain SM, Tan AR, Vidal G, Xiu J
|
|
|
14.
|
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Gallagher, Christopher
- Hofmeyer, Mark
- Lynce, Filipa
- Srichai, Monvadi B
- Swain, Sandra M
Year: 2021
Citation: - Breast Cancer Research & Treatment. 2021 Jan 05
Institution:
- MedStar Heart & Vascular Institute
- Washington Cancer Institute
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Asch F, Barac A, Dang C, Gallagher C, Geng X, Herbolsheimer P, Hofmeyer M, Isaacs C, Khoury K, Lynce F, Nunes R, Pohlmann PR, Smith KL, Srichai MB, Swain SM, Tan M, Warren R, Yu AF
|
|
|
15.
|
|
|
|
16.
|
BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer. MedStar authors:
Year: 2022
Citation: - Cancers. 14(11), 2022 May 24.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Colomer R, Dadswell K, Dang C, de Haas SL, de la Cruz-Merino L, Delaloge S, Eiger D, Ewer MS, Ferrero JM, Restuccia E, Sarkar S, Swain SM, Verrill M, Werner TL
|
|
|
17.
|
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology). MedStar authors:
Year: 2022
Citation: - Breast Cancer Research & Treatment. 2022 Mar 01
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Baez-Diaz L, Bandos H, Brufsky AM, Carolla RL, Fehrenbacher L, Geyer CE Jr, Hamm JT, Jacobs SA, Julian TB, Mamounas EP, Paterson AHG, Polikoff J, Provencher L, Rastogi P, Robidoux A, Swain SM, Ward PJ, Wolmark N
|
|
|
18.
|
Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer. MedStar authors:
Year: 2021
Citation: - Cancers. 13(9), 2021 May 08.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Aapro M, Abdel Aziz H, Abdel Karim K, Abulkhair O, Al-Sukhun S, Anderson BO, Aref AT, Arun B, Azim HA, Bahie Eldin N, Bakkach J, Balch CM, Conte P, El Saghir NS, El-Shinawi M, El-Zawahry HM, Elghazaly H, Elghazawy H, ElMahdy M, Foheidi M, Frolova M, Ghosn M, Giuliano AE, Gligorov J, Guarneri V, Gulluoglu BM, Kandil A, Leung JWT, Orecchia R, Paltuev RM, Penault-Llorca F, Perez EA, Poortmans P, Rugo HS, Sabry M, Shehata MA, Swain SM, Yang W, Yip CH
|
|
|
19.
|
Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis. MedStar authors:
Year: 2022
Citation: - Cancers. 14(20), 2022 Oct 15.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Cortazar P, Cortes J, Dang C, du Toit Y, Gianni L, Heinzmann D, Hurvitz SA, Jackisch C, Knott A, Macharia H, Schneeweiss A, Slamon D, Song C, Swain SM, Valagussa P
|
|
|
20.
|
|
|
|
21.
|
|
|
|
22.
|
|
|
|
23.
|
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology). MedStar authors:
Year: 2022
Citation: - Breast Cancer Research & Treatment. 193(3):565, 2022 Jun.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Baez-Diaz L, Bandos H, Brufsky AM, Carolla RL, Fehrenbacher L, Geyer CE Jr, Hamm JT, Jacobs SA, Julian TB, Mamounas EP, Paterson AHG, Polikoff J, Provencher L, Rastogi P, Robidoux A, Swain SM, Ward PJ, Wolmark N
|
|
|
24.
|
Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and management. [Review] MedStar authors:
Year: 2022
Citation: - Cancer Treatment Reviews. 106:102378, 2022 May.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Andre F, Bartholmai BJ, Conte P, Kato T, Lancaster LH, Li BT, Naidoo J, Nicholson AG, Nishino M, Powell CA, Schumacher-Wulf E, Shitara K, Swain SM, Tsurutani J
|
|
|
25.
|
|
|
|
26.
|
Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41. MedStar authors:
Year: 2023
Citation: - Breast Cancer Research & Treatment. 2023 Mar 22
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Rastogi P, Tang G, Hassan S, Geyer CE Jr, Azar CA, Magrinat GC, Suga JM, Bear HD, Baez-Diaz L, Sarwar S, Boileau JF, Brufsky AM, Shibata HR, Bandos H, Paik S, Yothers G, Swain SM, Mamounas EP, Wolmark N
|
|
|
27.
|
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up . MedStar authors:
Year: 2023
Citation: - Annals of Oncology. 2023 Dec 08
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Loibl S, Andre F, Bachelot T, Barrios CH, Bergh J, Burstein HJ, Cardoso LMJ, Carey LA, Dawood S, Del Mastro L, Denkert C, Fallenberg EM, Francis PA, Gamal-Eldin H, Gelmon K, Geyer CE, Gnant M, Guarneri V, Gupta S, Kim SB, Krug D, Martin M, Meattini I, Morrow M, Janni W, Paluch-Shimon S, Partridge A, Poortmans P, Pusztai L, Regan MM, Sparano J, Spanic T, Swain S, Tjulandin S, Toi M, Trapani D, Tutt A, Xu B, Curigliano G, Harbeck N
|
|
|
28.
|
Accessibility of clinical study reports supporting medicine approvals: a cross-sectional evaluation. MedStar authors:
Year: 2024
Citation: - Journal of Clinical Epidemiology. 167:111263, 2024 Mar.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Hopkins AM, Modi ND, Rockhold FW, Hoffmann T, Menz BD, Veroniki AA, McKinnon RA, Rowland A, Swain SM, Ross JS, Sorich MJ
|
|
|
29.
|
Evaluation of a longitudinal pharmacogenomics education on pharmacist knowledge in a multicampus healthcare system. MedStar authors:
- Hui, Adrian C
- Lee, Andrew J
- Smith, D Max
- Swain, Sandra M
- Walker, Alexander
Year: 2022
Citation: - Pharmacogenomics. 23(3):173-182, 2022 02.
Institution:
- MedStar Institute for Innovation
- MedStar Union Memorial Hospital
Department:
- Associate Dean for Research Development
- MedStar Health
- Pharmacogenomics
- Pharmacy
Medline publication type:
All authors: - Hui AC, Lee AJ, Peshkin BN, Smith DM, Swain SM, Walker AD
|
|
|
30.
|
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane. MedStar authors:
- Kurian, Shweta
- Mohebtash, Mahsa
- Ottaviano, Yvonne
- Rao, Suman
- Swain, Sandra M
Year: 2022
Citation: - Breast Cancer Research & Treatment. 196(3):571-581, 2022 Dec.
Institution: - MedStar Franklin Square Medical Center
Department:
- Associate Dean for Research Development
- Hematology/Oncology
- MedStar Health
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Randomized Controlled Trial
All authors: - Dilawari A, Graham D, Isaacs C, Kurian S, Lynce F, Mainor C, McNamara D, Mohebtash M, Ottaviano Y, Pohlmann PR, Rao S, Swain SM, Swanson N, Tan M, Warren R, Wu T
|
|
|
31.
|
Best-worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy. MedStar authors:
- Smith, D Max
- Swain, Sandra M
Year: 2022
Citation: - Implementation Science Communications. 3(1):52, 2022 May 14.
Department:
- Associate Dean for Research Development
- MedStar Health
- Pharmacogenomics
Medline publication type:
All authors: - Aquilante CL, Bates J, Beitelshees AL, Bishop JR, Blake KV, Cavallari LH, Cipriani A, Duong BQ, Elchynski AL, Empey PE, Formea CM, Hicks JK, Limdi NA, Mroz P, Oslin D, Pasternak AL, Petry N, Ramsey LB, Rowe E, Salloum RG, Schlichte A, Skaar TC, Smith DM, Swain SM, Tuteja S, Van Driest SL, Ward KM, Wiisanen K
|
|
|
32.
|
DPYD Testing: Time to Put Patient Safety First. MedStar authors:
- Smith, D Max
- Swain, Sandra M
Year: 2023
Citation: - Journal of Clinical Oncology. 41(15):2701-2705, 2023 May 20.
Department:
- Associate Dean for Research Development
- MedStar Health
- Pharmacogenomics
Medline publication type:
All authors: - Baker SD, Bates SE, Brooks GA, Dahut WL, Diasio RB, El-Deiry WS, Evans WE, Figg WD, Hertz DL, Hicks JK, Kamath S, Kasi PM, Knepper TC, McLeod HL, O'Donnell PH, Relling MV, Rudek MA, Sissung TM, Smith DM, Sparreboom A, Swain SM, Walko CM
|
|
|
33.
|
DPYD Testing: Time to Put Patient Safety First. MedStar authors:
- Smith, D Max
- Swain, Sandra M
Year: 2023
Citation: - Journal of Clinical Oncology. :JCO2202364, 2023 Feb 23
Department:
- Associate Dean for Research Development
- MedStar Health
- Pharmacogenomics
Medline publication type:
All authors: - Baker SD, Bates SE, Brooks GA, Dahut WL, Diasio RB, El-Deiry WS, Evans WE, Figg WD, Hertz DL, Hicks JK, Kamath S, Kasi PM, Knepper TC, McLeod HL, O'Donnell PH, Relling MV, Rudek MA, Sissung TM, Smith DM, Sparreboom A, Swain SM, Walko CM
|
|
|
34.
|
Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy. MedStar authors:
- Smith, D Max
- Swain, Sandra M
Year: 2022
Citation: - Clinical and translational science. 15(2):371-383, 2022 02.
Department:
- Associate Dean for Research Development
- MedStar Health
- Pharmacogenomics
Medline publication type:
All authors: - Aquilante CL, Bates J, Beitelshees AL, Bishop JR, Blake KV, Cavallari LH, Cipriani A, Duong BQ, Elchynski AL, Empey PE, Formea CM, Hicks JK, IGNITE Pharmacogenetics Working Group, Limdi NA, Mroz P, Oslin D, Pasternak AL, Petry N, Ramsey LB, Rowe E, Salloum RG, Schlichte A, Skaar TC, Smith DM, Swain SM, Tuteja S, Van Driest SL, Ward KM, Wiisanen K
|
|
|
35.
|
Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx R Digital Spatial Profiler. MedStar authors:
- Schlam, Ilana
- Swain, Sandra M
Year: 2021
Citation: - Cancers. 13(17), 2021 Sep 04.
Institution: - MedStar Washington Hospital Center
Department:
- Associate Dean for Research Development
- Hematology and Oncology
- MedStar Health
Medline publication type:
All authors: - Bergholtz H, Carter JM, Cesano A, Cheang MCU, Church SE, Divakar P, Fuhrman CA, Goel S, Gong J, Guerriero JL, Hoang ML, Hwang ES, Kuasne H, Lee J, Liang Y, Mittendorf EA, On Behalf Of The GeoMx Breast Cancer Consortium, Perez J, Prat A, Pusztai L, Reeves JW, Riazalhosseini Y, Richer JK, Sahin O, Sato H, Schlam I, Sorlie T, Stover DG, Swain SM, Swarbrick A, Thompson EA, Tolaney SM, Warren SE
|
|
|
36.
|
Pharmacogenetics in Practice: Estimating the Clinical Actionability of Pharmacogenetic Testing in Perioperative and Ambulatory Settings. MedStar authors:
- Brown, Ryan P
- Eldadah, Zayd A
- Hwang, Elizabeth
- Kmiecik, Susanna
- Levin, Bonnie
- Lundergan, Conor
- McAlduff, Joel
- Shapiro, Richard
- Smith, D Max
- Swain, Sandra M
Year: 2020
Citation: - Clinical and translational science. 13(3):618-627, 2020 05.
Institution:
- MedStar Health
- MedStar Heart & Vascular Institute
- MedStar Union Memorial Hospital
- MedStar Washington Hospital Center
- SiTEL
Department:
- Anesthesiology
- Associate Dean for Research Development
- Chief Medical Information Officer
- Pharmacogenomics
Medline publication type:
All authors: - Brown RP, Eldadah Z, Hwang E, Kmiecik S, Levin B, Lundergan C, McAlduff J, Peshkin BN, Shapiro R, Smith DM, Springfield TB, Swain SM
|
|
|
37.
|
Pharmacogenomic testing in oncology: a health system's approach to identify oncology provider perspectives. MedStar authors:
- Bhatt, Meghna
- Kazi, Sadaf
- Smith, D Max
- Swain, Sandra M
Year: 2023
Citation: - Pharmacogenomics. 24(16):859-870, 2023 Nov.
Institution:
- MedStar Institute for Innovation
- MedStar Washington Hospital Center
Department:
- Associate Dean for Research Development
- MedStar Health
- National Center for Human Factors in Healthcare
- Pharmacogenomics
- Pharmacy Residency
Medline publication type:
All authors: - Bhatt M, Peshkin BN, Kazi S, Schwartz MD, Ashai N, Swain SM, Smith DM
|
|
|
38.
|
Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing. MedStar authors:
- Brandt, Nicole
- Brown, Ryan P
- Levin, Bonnie
- Smith, D Max
- Swain, Sandra M
- Walsh, Richard J
- Welsh, James C
Year: 2020
Citation: - Pharmacogenomics. 21(15):1085-1094, 2020 10.
Department:
- Assistant Vice President
- Associate Dean for Research Development
- MedStar Center for Successful Aging
- MedStar Health
- Pharmacogenomics
- Vice President
Medline publication type:
All authors: - Brandt N, Brown RP, Levin B, Namvar T, Peshkin BN, Smith DM, Springfield TB, Swain SM, Walsh RJ, Welsh JC
|
